S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Modern Day Options Trading For Beginners! (Ad)pixel
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Insider Trading & Ownership

$0.12
0.00 (0.00%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.11
$0.12
50-Day Range
$0.10
$0.30
52-Week Range
$0.10
$0.61
Volume
692,020 shs
Average Volume
1.34 million shs
Market Capitalization
$17.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Adamis Pharmaceuticals (NASDAQ:ADMP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
0

ADMP Insider Buying and Selling by Quarter

Get ADMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adamis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Adamis Pharmaceuticals Insider Trades History

(Data available from 1/1/2013 forward)












ADMP Insider Trading Activity - Frequently Asked Questions

Who is on Adamis Pharmaceuticals's Insider Roster?

The list of insiders at Adamis Pharmaceuticals includes David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K. Daniels, Robert O Hopkins, and Ronald B Moss. Learn more on insiders at ADMP.

What percentage of Adamis Pharmaceuticals stock is owned by insiders?

5.90% of Adamis Pharmaceuticals stock is owned by insiders. Learn more on ADMP's insider holdings.

Which Adamis Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ADMP shares in the last 24 months: David C Benedicto ($2,197.83), David J Marguglio ($7,115.40), Dennis J Phd Carlo ($6,294.00), and Ronald B Moss ($4,919.40).

How much insider selling is happening at Adamis Pharmaceuticals?

Insiders have sold a total of 34,151 Adamis Pharmaceuticals shares in the last 24 months for a total of $20,526.63 sold.

This page (NASDAQ:ADMP) was last updated on 3/29/2023 by MarketBeat.com Staff